PT Suparma Tbk (ISX:SPMA) 1-Year Sharpe Ratio: 0.01 (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SPMA PT Suparma Tbk ISX:SPMA
82 GF Score
Price Rp164.00
GF Value Rp186.32
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is PT Suparma Tbk 1-Year Sharpe Ratio?

PT Suparma Tbk ISX:SPMA +0.61% 82 1-Year Sharpe Ratio is 0.01 as of Aug. 10, 2026. GuruFocus rates ISX:SPMA with a GF Score™ of 82/100 and a GF Value™ of Rp186.32 (Modestly Undervalued). The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-10), PT Suparma Tbk's 1-Year Sharpe Ratio is 0.01.


PT Suparma Tbk  (ISX:SPMA) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


PT Suparma Tbk 1-Year Sharpe Ratio Related Terms


ISX:SPMA vs SLVM: 1-Year Sharpe Ratio Comparison

For the Paper & Paper Products subindustry, PT Suparma Tbk's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Suparma Tbk 1-Year Sharpe Ratio vs Forest Products Industry

For the Forest Products industry and Basic Materials sector, PT Suparma Tbk's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where PT Suparma Tbk's 1-Year Sharpe Ratio falls into.


ISX:SPMA
82GF Score
PT Suparma Tbk ISX:SPMA
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Suparma Tbk 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.01 mean?
PT Suparma Tbk (ISX:SPMA) has a 1-Year Sharpe Ratio of 0.01 as of Aug. 10, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for PT Suparma Tbk and its competitors.
Is PT Suparma Tbk's 1-Year Sharpe Ratio too high?
PT Suparma Tbk's current 1-Year Sharpe Ratio is 0.01. Overall, PT Suparma Tbk has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Suparma Tbk's 1-Year Sharpe Ratio compare to SLVM?
PT Suparma Tbk's 1-Year Sharpe Ratio of 0.01 can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Forest Products company?
A good 1-Year Sharpe Ratio depends on the Forest Products industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for PT Suparma Tbk and its competitors. PT Suparma Tbk's current 1-Year Sharpe Ratio is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Suparma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Suparma Tbk (ISX:SPMA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp186.32, compared to a current price of Rp164.00 — trading 12% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.01. PT Suparma Tbk's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For PT Suparma Tbk (ISX:SPMA), the current 1-Year Sharpe Ratio is 0.01 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Suparma Tbk (ISX:SPMA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Suparma Tbk stock appears to be undervalued. The current stock price of Rp164.00 is trading 12% below its estimated GF Value™ of Rp186.32. GuruFocus considers PT Suparma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:SPMA:

  • 1-Year Sharpe Ratio: 0.01
  • GF Value™: Rp186.32 vs. price of Rp164.00 (12% below fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the ISX:SPMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Suparma Tbk Business Description

Address Jalan Raya Mastrip, No. 856 Warugunung, Karangpilang, East Java, Surabaya, IDN, 60221
PT Suparma Tbk is an Indonesia-based company that manufactures paper and paper products. The group manufactured paper and paper wrapping products for the industrial and consumer sectors. The firm offers Laminated Wrapping Kraft, Samson Kraft, MG Paper, Coated Duplex Board, Bathroom Tissue, Carrier Tissue, Industrial Roll Towel, Kitchen Towel, and Other products. Geographically, the firm generates the majority of its revenue from the local market.
82GF Score

Get the complete analysis for ISX:SPMA

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp164.00
Price
Rp186.32
GF Value